Skip to main content
Vitrolife logo

Vitrolife — Investor Relations & Filings

Ticker · VITR ISIN · SE0011205202 LEI · 5493001WDZMONMSPPR49 ST Manufacturing
Open in API
Filings indexed 656 across all filing types
Latest filing 2011-10-20 Report Publication Anno…
Country SE Sweden
Listing ST VITR

About Vitrolife

https://www.vitrolife.com/

Vitrolife is a global company focused on reproductive health, providing medical devices and genetic testing services primarily to In Vitro Fertilization (IVF) clinics. The company develops, produces, and markets a comprehensive portfolio of products and solutions that support the entire assisted reproduction treatment journey, from oocyte retrieval and sperm preparation to fertilization, embryo culture, evaluation, transfer, and cryopreservation. With a strong emphasis on quality control, innovation, and clinical support, Vitrolife aims to improve treatment outcomes and operational efficiency for its partners. The company also offers educational resources and training for professionals through its Vitrolife Academy.

Recent filings

Filing Released Lang Actions
Telefonkonferens avseende delårsrapport
Report Publication Announcement Classification · 98% confidence The document is a press release dated October 20, 2011, announcing a telephone conference regarding the interim report (delårsrapport) for January – September 2011. Crucially, it states: "Ett pressmeddelande med Vitrolifes delårsrapport kommer att publiceras kl. 08.30 samma dag." (A press release with Vitrolife's interim report will be published at 08:30 the same day.) and mentions that presentation material will be available on the website before the conference. Since the document itself is an announcement about the upcoming release of the interim report and the associated conference call, and given its short length (3131 chars), it fits the definition of a Report Publication Announcement (RPA) rather than the comprehensive Interim Report (IR) itself. It is announcing the publication of the report.
2011-10-20 Swedish
Conference call on the report on interim report
Report Publication Announcement Classification · 99% confidence The document is explicitly titled 'Conference call on the report on interim report' and serves as an invitation to attend a conference call where the interim report for January - September 2011 will be presented. It provides details (date, time, dial-in) for the call and mentions that the press release for the interim report will be released separately. Since this document is an announcement about an upcoming event (a conference call) related to the release of an interim financial report, it is not the report itself (which would be 'IR'). It is an announcement regarding the presentation of financial results, which aligns closely with the purpose of a Call Transcript (CT) announcement or a general Regulatory Filing (RNS). However, given the specific focus on announcing the *conference call* for the interim report presentation, and the fact that it is not the transcript itself, it functions as a precursor announcement. The closest fit among the options that describes an announcement related to financial results presentation/call, but isn't the full report or the transcript, is often categorized under general regulatory announcements or specific call-related materials. Since 'CT' is defined as the *full text transcript*, and this is an *invitation* to the call, 'RNS' (Regulatory Filings/miscellaneous announcements) is the most appropriate fallback, although 'RPA' (Report Publication Announcement) is also plausible as it announces the event surrounding the report's discussion. Given the content is purely an invitation to a conference call about an interim report, I will classify it as RNS as it is a general announcement about an upcoming event related to financial reporting, rather than the report itself or the transcript.
2011-10-20 English
First third of STEEN Solution™ study in USA completed.
Regulatory Filings Classification · 95% confidence The document is a 'Press Release' dated October 11, 2011, providing an update on a clinical study (STEEN Solution™ study in the USA) involving FDA consultation and progress towards sales approval. It details operational milestones (number of patients transplanted, centers involved) and provides context on the medical technology. This type of operational/progress update, especially one that is not a formal financial report (like 10-K or IR) or a specific regulatory filing like DIRS or DIV, fits best under the general category for miscellaneous regulatory or corporate announcements that don't fit elsewhere, which is Regulatory Filings (RNS). It is not an Earnings Release (ER) as it contains no financial results, nor is it a Call Transcript (CT) or Investor Presentation (IP). Given its nature as a general corporate update on a business development milestone, RNS is the most appropriate fallback.
2011-10-11 English
Första tredjedelen av STEEN Solution™ studien i USA avklarad.
Regulatory Filings Classification · 91% confidence The document is a press release (Pressmeddelande) dated October 11, 2011, providing an update on a clinical study (STEEN Solution™ study in the USA) related to organ transplantation technology. It discusses progress towards regulatory approval (FDA) and mentions results from a previous Canadian study. This type of announcement, detailing operational progress, clinical trial milestones, and regulatory pathways, is typically classified as a general corporate update or regulatory filing, but it does not fit the specific definitions for Earnings Release (ER), Interim Report (IR), Annual Report (10-K), or a specific financing/legal event. Since it is a formal announcement providing operational and strategic progress, and it is not a short announcement pointing to a larger report (RPA), the most appropriate general category for significant corporate news that doesn't fit elsewhere is Regulatory Filings (RNS), as it is a formal communication to the market about a key business development impacting future sales/approvals. Given the context of a press release updating on a clinical trial progress towards market approval, it functions as a general regulatory/corporate update.
2011-10-11 Swedish
Ökad tillväxtpotential – regulatoriskt godkännande i Japan av aspirationsnålar på den näst största IVF marknaden.
Regulatory Filings Classification · 95% confidence The document is a short press release (2939 characters) dated October 7, 2011, announcing that Vitrolife has received regulatory approval in Japan for selling specific medical devices (aspiration needles and micropipettes) used in IVF treatments. This announcement concerns a specific business development, regulatory milestone, and market expansion, rather than a full financial report (10-K, IR, ER) or a general shareholder communication (DEF 14A, AGM-R). Since it is a specific, non-financial regulatory/business update that doesn't fit the other specific categories (like M&A, Director Dealing, Dividend), it falls best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous regulatory announcements not covered elsewhere. It is not a Report Publication Announcement (RPA) because it is announcing an event/approval, not the publication of a separate, attached report.
2011-10-07 Swedish
Increased sales potential - Regulatory approval in Japan for aspiration needles opens the second largest IVF market.
Regulatory Filings Classification · 95% confidence The document is a short press release dated October 7, 2011, announcing regulatory approval in Japan for IVF products. It details a business development event (market access expansion) rather than comprehensive financial results (like 10-K or IR), management changes (MANG), or shareholder voting results (DVA). It is not a formal regulatory filing like a 10-K or an Earnings Release (ER). Since it announces a specific business event/update that doesn't fit the other specific categories (like M&A, Capital Change, Dividend), it falls best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous regulatory or significant business announcements that aren't covered elsewhere, especially when the content is a press release format.
2011-10-07 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.